# Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.

> **NCT04115527** · NA · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **PROCEDURE:** Extended Lymphadenectomy
- **PROCEDURE:** Standard Lymphadenectomy

## Key facts

- **NCT ID:** NCT04115527
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04115527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04115527, "Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04115527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*